Amprenavirs antivirale in vitro- aktivitet blev evalueret over for HIV- 1- IIIB i både akut og kronisk inficerede lymfoblastiske cellelinier (MT- 4, CEM- CCRF, H9) og perifere blodlymfocytter.
The in vitro antiviral activity of amprenavir was evaluated against HIV-1 IIIB in both acutely and chronically infected lymphoblastic cell lines (MT-4, CEM-CCRF, H9) and in peripheral blood lymphocytes.